Clinical Trial Update: Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer

View source ↗

Summary

Clinical trial update for ultrahypofractionated adaptive radiotherapy in prostate cancer; the study (NCT06355050) is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Jena University Hospital | Conditions: Prostate Cancer, Adaptive Radiotherapy | Status: NOT_YET_RECRUITING